Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia

被引：10

作者：

Jain, Preetesh ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Ravandi, Farhad ^{[1
]}

Jabbour, Elias ^{[1
]}

Daver, Naval ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Alvarado, Yesid ^{[1
]}

Jain, Nitin ^{[1
]}

Borthakur, Gautam ^{[1
]}

Verstovsek, Srdan ^{[1
]}

Ferrajoli, Alessandra ^{[1
]}

Ohanian, Maro ^{[1
]}

Konopleva, Marina ^{[1
]}

Naqvi, Kiran ^{[1
]}

Fitch, Tina ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Cortes, Jorge E. ^{[1
]}

Estrov, Zeev ^{[1
]}

Kadia, Tapan M. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.1639.1639

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1639

引用

页数：6

共 50 条

[41] TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA WITH ARA-C IN LOW DOSAGE
PESCE, A
CASSUTO, JP
BAYLE, J
FUZIBET, JG
RAYNAUD, S
GRATECOS, N
DUJARDIN, P
PRESSE MEDICALE, 1985, 14 (43): : 2198 - 2198
[42] Phase II Study of Cladribine, Idarubicin, and Cytarabine (araC) in Patients with Acute Myeloid Leukemia (AML)
Kadia, Tapan
Cortes, Jorge E.
Jabbour, Elias J.
Daver, Naval
Pemmaraju, Naveen
Ravandi, Farhad
Jain, Nitin
Verstovsek, Srdan
DiNardo, Courtney
Alvarado, Yesid
Ferrajoli, Alessandra
Burger, Jan A.
Garcia-Manero, Guillermo
Ohanian, Maro
Konopleva, Marina
Estrov, Zeev
Wierda, William
Brandt, Mark
Fitch, Tina
Borthakur, Gautam
Kantarjian, Hagop M.
BLOOD, 2015, 126 (23)
[43] High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia:: a pharmacokinetic and clinical study
Tedeschi, Alessandra
Montillo, Marco
Strocchi, Elena
Cafro, Anna Maria
Tresoldi, Elisabetta
Intropido, Liliana
Nichelatti, Michele
Marbello, Laura
Barate, Claudia
Camaggi, Carlo Maurizio
Morra, Enrica
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 771 - 779
[44] IDARUBICIN AND HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS
SPIRITI, MAA
TESTI, AM
AMADORI, S
DEFABRITIIS, P
GIONA, F
SANDRELLI, A
MELONI, G
ACTA HAEMATOLOGICA, 1987, 78 : 213 - 213
[45] MITOXANTRONE AND ARA-C IN PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
PACIUCCI, PA
DUTCHER, JP
CUTTNER, J
STRAUMAN, JJ
WIERNIK, PH
HOLLAND, JF
LEUKEMIA, 1987, 1 (07) : 565 - 567
[46] Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Heo, Sook-Kyoung
Noh, Eui-Kyu
Yu, Ho-Min
Kim, Do Kyoung
Seo, Hye Jin
Lee, Yoo Jin
Cheon, Jaekyung
Koh, Su Jin
Min, Young Joo
Choi, Yunsuk
Jo, Jae-Cheol
BMC CANCER, 2020, 20 (01)
[47] THE RELATIONSHIP OF ARA-C METABOLISM INVITRO TO THERAPEUTIC RESPONSE IN ACUTE MYELOID-LEUKEMIA
HARRIS, AL
GRAHAMESMITH, DG
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (01) : 30 - 35
[48] High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study
Alessandra Tedeschi
Marco Montillo
Elena Strocchi
Anna Maria Cafro
Elisabetta Tresoldi
Liliana Intropido
Michele Nichelatti
Laura Marbello
Claudia Baratè
Carlo Maurizio Camaggi
Enrica Morra
Cancer Chemotherapy and Pharmacology, 2007, 59 : 771 - 779
[49] Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Sook-Kyoung Heo
Eui-Kyu Noh
Ho-Min Yu
Do Kyoung Kim
Hye Jin Seo
Yoo Jin Lee
Jaekyung Cheon
Su Jin Koh
Young Joo Min
Yunsuk Choi
Jae-Cheol Jo
BMC Cancer, 20
[50] Idarubicin, ara-c, and topotecan in patients with refractory or relapased acute myelogenous leukemia and high-risk myelodysplastic syndrome.
Min, YH
Jang, JH
Lee, ST
Hahn, JS
Ko, YW
BLOOD, 1999, 94 (10) : 234B - 234B

← 1 2 3 4 5 →